Gilder Gagnon Howe & CO LLC Pacific Biosciences Of California, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $383,196 - $598,471	-19,896 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.86 - $35.02 $8,477 - $11,941	-341 Reduced 1.69%	19,896 $508,000
Q2 2021 Aug 16, 2021	SELL	$22.3 - $36.02 $1,538 - $2,485	-69 Reduced 0.34%	20,237 $708,000
Q1 2021 May 17, 2021	SELL	$26.38 - $51.15 $636,417 - $1.23 Million	-24,125 Reduced 54.3%	20,306 $676,000
Q4 2020 Feb 16, 2021	BUY	$10.5 - $28.5 $466,525 - $1.27 Million	44,431 New	44,431 $1.15 Million
Q1 2018 Apr 30, 2018	SELL	$2.05 - $3.23 $17,750 - $27,968	-8,659 Closed	0 $0
Q4 2017 Jan 31, 2018	SELL	$2.59 - $5.44 $37,223 - $78,183	-14,372 Reduced 62.4%	8,659 $23,000
Q3 2017 Nov 06, 2017	BUY	$3.2 - $5.57 $73,699 - $128,282	23,031	23,031 $121,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.